Colgate-Palmolive (CL) CFO Form 4 shows 385 shares withheld for taxes

Rhea-AI Filing Summary

Colgate-Palmolive Company’s Chief Financial Officer, reported on a Form 4 that shares of company stock were withheld to cover taxes on previously granted restricted stock units. On 12/03/2025, 385 shares of common stock were disposed of at a price of $78.2 per share through tax withholding, coded as transaction type "F," which indicates payment of tax liability from equity awards.

After this transaction, the officer beneficially owns 55,310 shares of Colgate-Palmolive common stock directly, and an additional 326 shares indirectly through the issuer’s 401(k) plan trustee. The filing clarifies that the underlying restricted stock units remain held by the officer, reduced only by the amount required for Medicare and income tax withholding.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SUTULA STANLEY J III

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/03/2025		F(1)		385	D	$78.2	55,310	D
Common Stock								326	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.

	/s/ Kristine Hutchinson, Attorney-in-Fact	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Colgate-Palmolive (CL) report in this Form 4?

The Chief Financial Officer reported that 385 shares of Colgate-Palmolive common stock were withheld on 12/03/2025 to pay Medicare and income tax obligations related to previously granted restricted stock units.

What does the transaction code "F" mean in the Colgate-Palmolive (CL) Form 4?

The transaction code "F" indicates a payment of tax liability by withholding shares of stock from equity awards, in this case restricted stock units granted under Colgate-Palmolive’s incentive compensation plan.

How many Colgate-Palmolive (CL) shares does the CFO own after this transaction?

Following the tax withholding transaction, the CFO beneficially owns 55,310 shares of Colgate-Palmolive common stock directly and 326 shares indirectly through the issuer’s 401(k) plan trustee.

Were the restricted stock units for Colgate-Palmolive (CL) cancelled in this Form 4 event?

No. The explanation states that the officer continues to hold the restricted stock units originally granted, reduced only by the number of shares withheld to satisfy the required tax withholding.

At what price were the Colgate-Palmolive (CL) shares withheld for taxes?

The 385 shares of Colgate-Palmolive common stock used for tax withholding were valued at $78.2 per share as reported in the Form 4.

What is the nature of the indirect ownership reported for Colgate-Palmolive (CL) shares?

The Form 4 reports 326 shares of Colgate-Palmolive common stock held indirectly by the officer through the issuer’s 401(k) plan trustee.